Familial Cancer

, Volume 13, Issue 2, pp 231–242 | Cite as

Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations—a clinical observational study

  • Linda Bardram
  • Thomas V. O. Hansen
  • Anne-Marie Gerdes
  • Susanne Timshel
  • Lennart Friis-Hansen
  • Birgitte Federspiel
Original Article


Inactivating mutations in the CDH1 (E-cadherin) gene are the predisposing cause of gastric cancer in most families with hereditary diffuse gastric cancer (HDGC). The lifetime risk of cancer in mutation positive members is more than 80 % and prophylactic total gastrectomy is recommended. Not all mutations in the CDH1 gene are however pathogenic and it is important to classify mutations before this major operation is performed. Probands from two Danish families with gastric cancer and a history suggesting HDGC were screened for CDH1 gene mutations. Two novel CDH1 gene mutations were identified and found pathogenic. In silico and mini-gene assay were used to predict the functional consequence in one of them. Mutation carriers were offered endoscopy and total gastrectomy. The gastric specimens were completely sectioned and examined histologically. Seven asymptomatic mutation carriers were operated. Hospital stay was 6–8 days and there were no complications. Small foci of diffuse gastric cancer were found in all patients—intramucosal in six and advanced in one. Preoperative endoscopic biopsies had revealed a microscopic cancer focus in two of the patients. Our data confirmed the pathogenic nature of both mutations and strongly support the recommendation of total gastrectomy in asymptomatic CDH1 gene mutation carriers. The functional consequences of novel CDH1 gene mutations with uncertain effects should be tested before correct advice and treatment can be given.


CDH-1 mutation Prophylactic gastrectomy Hereditary gastric cancer Functional mutation study In silico analysis 


Conflict of interest



  1. 1.
    Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G et al (1990) Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 66(9):2047–2051 Epub 1990/11/01PubMedCrossRefGoogle Scholar
  2. 2.
    Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549 Epub 1993/05/01PubMedGoogle Scholar
  3. 3.
    Shinmura K, Goto M, Tao H, Shimizu S, Otsuki Y, Kobayashi H et al (2005) A novel STK11 germline mutation in two siblings with Peutz-Jeghers syndrome complicated by primary gastric cancer. Clin Genet 67(1):81–86 Epub 2004/12/25PubMedCrossRefGoogle Scholar
  4. 4.
    Takahashi M, Sakayori M, Takahashi S, Kato T, Kaji M, Kawahara M et al (2004) A novel germline mutation of the LKB1 gene in a patient with Peutz-Jeghers syndrome with early-onset gastric cancer. J Gastroenterol 39(12):1210–1214 Epub 2004/12/29PubMedCrossRefGoogle Scholar
  5. 5.
    Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD, Santibanez-Koref MF et al (1995) An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet 32(12):942–945 Epub 1995/12/01PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubinski J (2002) BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer 87(8):888–891 Epub 2002/10/10PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T et al (2003) A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Eur J Hum Genet 11(12):955–958 Epub 2003/12/03PubMedCrossRefGoogle Scholar
  8. 8.
    Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P et al (2012) Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut 61(5):774–779 Epub 2011/08/05PubMedCrossRefGoogle Scholar
  9. 9.
    Carneiro FCA, Huntsman DG (2010) Hereditary diffuse gastric cancer. In: Bosman FTCF, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system, 4th edn. IARC, Lyon, pp 59–63Google Scholar
  10. 10.
    Jones EG (1964) Familial Gastric Cancer. The New Zealand Med J 63:287–296 Epub 1964/05/01Google Scholar
  11. 11.
    Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402–405 Epub 1998/04/16PubMedCrossRefGoogle Scholar
  12. 12.
    Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36(12):873–880 Epub 1999/12/14PubMedCentralPubMedGoogle Scholar
  13. 13.
    Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V et al (2010) Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 47(7):436–444 Epub 2010/07/02PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, de Jong D, van Krieken JH, et al. (2012) Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer 11(3):363–369 Epub 2012/03/06Google Scholar
  15. 15.
    Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N et al (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA, J Am Med Assoc 297(21):2360–2372 Epub 2007/06/05CrossRefGoogle Scholar
  16. 16.
    Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N et al (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 41(7):508–517 Epub 2004/07/06PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Pharoah PD, Guilford P, Caldas C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6):1348–1353 Epub 2001/12/01PubMedCrossRefGoogle Scholar
  18. 18.
    Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Nogues C et al (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486–489 Epub 2013/05/28PubMedCrossRefGoogle Scholar
  19. 19.
    Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A et al (2009) Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 18(9):1545–1555 Epub 2009/01/27PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Guilford P, Humar B, Blair V (2010) Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 13(1):1–10 Epub 2010/04/08PubMedCrossRefGoogle Scholar
  21. 21.
    Pinheiro H, Bordeira-Carrico R, Seixas S, Carvalho J, Senz J, Oliveira P et al (2010) Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 19(5):943–952 Epub 2009/12/08PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F (2012) Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer 12:8 Epub 2012/01/10PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F (2013) E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 116:337–359 Epub 2013/03/14PubMedCrossRefGoogle Scholar
  24. 24.
    Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS et al (2012) Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol 36(11):1709–1717 Epub 2012/10/18PubMedCrossRefGoogle Scholar
  25. 25.
    Baralle D, Baralle M (2005) Splicing in action: assessing disease causing sequence changes. J Med Genet 42(10):737–748 Epub 2005/10/04PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4(3):311–323 Epub 1997/10/01PubMedCrossRefGoogle Scholar
  27. 27.
    Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11(2–3):377–394 Epub 2004/08/03PubMedCrossRefGoogle Scholar
  28. 28.
    Hansen TV, Steffensen AY, Jonson L, Andersen MK, Ejlertsen B, Nielsen FC (2010) The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Res Treat 119(3):547–550 Epub 2009/03/10PubMedCrossRefGoogle Scholar
  29. 29.
    Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H et al (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14(3):249–255 Epub 1999/09/08PubMedCrossRefGoogle Scholar
  30. 30.
    Mastoraki A, Danias N, Arkadopoulos N, Sakorafas G, Vasiliou P, Smyrniotis V (2011) Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature. Surg Oncol 20(4):e223–e226 Epub 2011/08/30PubMedCrossRefGoogle Scholar
  31. 31.
    Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simoes-Correia J et al (2012) CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 131(2):367–376 Epub 2011/10/25PubMedCrossRefGoogle Scholar
  32. 32.
    Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS (2011) Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery 149(3):347–355 Epub 2010/08/20PubMedCrossRefGoogle Scholar
  33. 33.
    Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. (2012) A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric cancer 15 Suppl 1: S153–163 Epub 2011/12/14Google Scholar
  34. 34.
    Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG et al (2001) Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. New England J Med 344(25):1904–1909 Epub 2001/06/23CrossRefGoogle Scholar
  35. 35.
    Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ et al (2001) Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer 92(1):181–187 Epub 2001/07/10PubMedCrossRefGoogle Scholar
  36. 36.
    Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P et al (2004) Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 203(2):681–687 Epub 2004/05/14PubMedCrossRefGoogle Scholar
  37. 37.
    Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W et al (2010) Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Eur J Gastroenterol Hepatol 22(3):306–310 Epub 2009/05/29PubMedCrossRefGoogle Scholar
  38. 38.
    Francis WP, Rodrigues DM, Perez NE, Lonardo F, Weaver D, Webber JD (2007) Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer. JSLS 11(1):142–147 Epub 2007/07/27PubMedCentralPubMedGoogle Scholar
  39. 39.
    Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T et al (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3(4):219–225 Epub 2002/05/02PubMedCrossRefGoogle Scholar
  40. 40.
    Choi J, Kim SG, Im JP, Kang SJ, Lee HJ, Yang HK et al (2011) Lymph node metastasis in multiple synchronous early gastric cancer. Gastrointest Endosc 74(2):276–284 Epub 2011/08/02PubMedCrossRefGoogle Scholar
  41. 41.
    Kang HJ, Kim DH, Jeon TY, Lee SH, Shin N, Chae SH et al (2010) Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointest Endosc 72(3):508–515 Epub 2010/06/18PubMedCrossRefGoogle Scholar
  42. 42.
    Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11):2069–2077 Epub 2004/04/15PubMedCrossRefGoogle Scholar
  43. 43.
    Liedman B (1999) Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients-is reconstruction with a reservoir worthwhile? Nutrition 15(9):677–682 Epub 1999/09/01PubMedCrossRefGoogle Scholar
  44. 44.
    Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG (2010) Pregnancy after prophylactic total gastrectomy. Fam Cancer 9(3):331–334 Epub 2010/01/12PubMedCrossRefGoogle Scholar
  45. 45.
    Oliveira CPH, Figueiredo J, Seruca R, Carnerio F (2013) E-Cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 116:337–359PubMedCrossRefGoogle Scholar
  46. 46.
    Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J et al (2008) Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 7(1):73–82 Epub 2007/11/30PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG et al (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 32(6):799–809 Epub 2008/04/09PubMedCrossRefGoogle Scholar
  48. 48.
    Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M et al (2002) Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 21(53):8192–8195 Epub 2002/11/22PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Linda Bardram
    • 1
  • Thomas V. O. Hansen
    • 2
  • Anne-Marie Gerdes
    • 3
  • Susanne Timshel
    • 4
  • Lennart Friis-Hansen
    • 2
  • Birgitte Federspiel
    • 5
  1. 1.Department of Surgical GastroenterologyRigshospitalet, University of CopenhagenCopenhagenDenmark
  2. 2.Department of Genomic MedicineRigshospitalet, University of CopenhagenCopenhagenDenmark
  3. 3.Department of Clinical GeneticsRigshospitalet, University of CopenhagenCopenhagenDenmark
  4. 4.The Kennedy CenterRigshospitalet, University of CopenhagenCopenhagenDenmark
  5. 5.Department of PathologyRigshospitalet, University of CopenhagenCopenhagenDenmark

Personalised recommendations